Journal
ACS MEDICINAL CHEMISTRY LETTERS
Volume 8, Issue 7, Pages 726-731Publisher
AMER CHEMICAL SOC
DOI: 10.1021/acsmedchemlett.7b00127
Keywords
MAPK; inhibitor; peptide; melanoma; cancer; click chemistry; structure-based drug design
Categories
Funding
- NIH [R01CA160457, P41RR012408, P41GM103473, P41GM103393]
- NCI Cancer Center Support [P30CA030199]
- EMBO Long Term Postdoctoral Fellowship
- DOD-BCRP Fellowship [BC100466]
- U.S. Department of Energy [DE-ACO2-76SF00515]
Ask authors/readers for more resources
ERK is the effector kinase of the RAS-RAF-MEK-ERK signaling cascade, which promotes cell transformation and malignancy in many cancers and is thus a major drug target in oncology. Kinase inhibitors targeting RAF or MEK are already used for the treatment of certain cancers, such as melanoma. Although the initial response to these drugs can be dramatic, development of drug resistance is a major challenge, even with combination therapies targeting both RAF and MEK. Importantly, most resistance mechanisms still rely on activation of the downstream effector kinase ERIC, making it a promising target for drug development efforts. Here, we report the design and structural/functional characterization of a set of bivalent ERIC inhibitors that combine a small molecule inhibitor that binds to the ATP-binding pocket with a peptide that selectively binds to an ERIC protein interaction surface, the D-site recruitment site (DRS). Our studies show that the lead bivalent inhibitor, SBP3, has markedly improved potency compared to the small molecule inhibitor alone. Unexpectedly, we found that SBP3 also binds to several ERKrelated kinases that contain a DRS, highlighting the importance of experimentally verifying the predicted specificity of bivalent inhibitors. However, SBP3 does not target any other kinases belonging to the same CMGC branch of the kinome. Additionally, our modular click chemistry inhibitor design facilitates the generation of different combinations of small molecule inhibitors with ERIC-targeting peptides.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available